Document Detail

Clozapine-induced myocarditis: is mandatory monitoring warranted for its early recognition?
MedLine Citation:
PMID:  24587933     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Clozapine is an atypical antipsychotic used for treatment resistant schizophrenia. Its potential to induce agranulocytosis is well known but it can also cause myocarditis. Clozapine is the only antipsychotic known to induce this side effect, typically early in the treatment, and literature is scarce on this condition. We are presenting a case report of a 21-year-old schizophrenic male who developed myocarditis within 3 weeks of starting on clozapine for his treatment resistant psychosis. We then aim to review some of the available literature and raise awareness among physicians as this condition can potentially be fatal if not detected early.
T A Munshi; D Volochniouk; T Hassan; N Mazhar
Related Documents :
15125293 - Spontaneous retropharyngeal haematoma: two cases and a review of the literature.
4038143 - Intramuscular myxoma of the neck.
2236733 - Hyperlactatemia and increasing metabolic acidosis in hepatorenal failure treated by hem...
Publication Detail:
Type:  Journal Article     Date:  2014-01-23
Journal Detail:
Title:  Case reports in psychiatry     Volume:  2014     ISSN:  2090-682X     ISO Abbreviation:  Case Rep Psychiatry     Publication Date:  2014  
Date Detail:
Created Date:  2014-03-03     Completed Date:  2014-03-03     Revised Date:  2014-03-05    
Medline Journal Info:
Nlm Unique ID:  101583308     Medline TA:  Case Rep Psychiatry     Country:  United States    
Other Details:
Languages:  eng     Pagination:  513108     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A treatable neurometabolic disorder: glutaric aciduria type 1.
Next Document:  Effectiveness of saikokaryukotsuboreito (herbal medicine) for antipsychotic-induced sexual dysfuncti...